Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3223]

$FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large B-cell lymphoma$

FDA approves brentuximab vedotin with lenalidomide and rituximab for relapsed or refractory large B-cell lymphoma

Gene modification could improve cancer treatment's success rate

Gene modification could improve cancer treatment's success rate

FDA approves treosulfan with fludarabine as a preparative regimen for alloHSCT in adult and paediatric patients with AML or MDS

FDA approves treosulfan with fludarabine as a preparative regimen for alloHSCT in adult and paediatric patients...

CAR-T cells can arm bystander T cells with CAR molecules via trogocytosis

CAR-T cells can arm bystander T cells with CAR molecules via trogocytosis

New research a step toward off-the-shelf CAR T cell therapy for cancer

New research a step toward off-the-shelf CAR T cell therapy for cancer

EC approval for blinatumomab in Philadelphia chromosome-negative CD19-positive B-cell precursor acute lymphoblastic leukaemia in the consolidation phase

EC approval for blinatumomab in Philadelphia chromosome-negative CD19-positive B-cell precursor acute...

Researchers pioneer DNA-tagged gold nanoparticles for targeted cancer treatment

Researchers pioneer DNA-tagged gold nanoparticles for targeted cancer treatment

Cancer risk established before birth

Cancer risk established before birth

Investigators pinpoint keys to cell therapy response for leukaemia

Investigators pinpoint keys to cell therapy response for leukaemia

Trial reveals major advance in treatment of aggressive lymphoma

Trial reveals major advance in treatment of aggressive lymphoma

More from ecancer